The ability to fabricate sensory systems capable of highly selective operation in complex fluid will undoubtedly underpin key future developments in healthcare. However, the abundance of (bio)molecules in these samples can significantly impede performance at the transducing interface where nonspecific adsorption (fouling) can both block specific signal (reducing sensitivity) and greatly reduce assay specificity. Herein, we aim to provide a comprehensive review discussing concepts and recent advances in the construction of antifouling sensors that are, through the use of chemical, physical, or biological engineering, capable of operating in complex sample matrix (e.g., serum). We specifically highlight a range of molecular approaches to the construction of solid sensory interfaces (planar and nanoparticulate) and their characterization and performance in diverse in vitro and in vivo analyte (e.g., proteins, nucleic acids, cells, neuronal transmitters) detection applications via derived selective optical or electrochemical strategies. We specifically highlight those sensors that are capable of detection in complex media or those based on novel architectures/approaches. Finally, we provide perspectives on future developments in this rapidly evolving field.
The
rapid, convenient, and selective assaying of clinical targets
directly in complex biological media brings with it the potential
to revolutionize diagnostics. One major hurdle to impact is retention
of selectivity and a tight control of nonspecific surface interactions
or biofouling. We report herein, the construction of an antifouling
interface through the covalent attachment of designed branched zwitterionic
peptides onto electrodeposited polyaniline film. The antifouling capability
of the designed branched peptide significantly outperforms that of
the commonly used PEG and linear peptides. The interfaces modified
with branched peptides are exceptionally effective in reducing a nonspecific
protein and cell adsorption, as verified by electrochemical and fluorescent
characterization. The derived sensors with mucin1 protein (MUC1) aptamer
as the recognition element detect MUC1-positive MCF-7 breast cancer
cells in human serum with high sensitivity and selectivity. The linear
response range of the cytosensor for the MCF-7 cell is from 50 to
106 cells/mL, with a limit of detection as low as 20 cells/mL.
More importantly, the assaying performances remain unchanged in human
serum owing to the presence of branched antifouling peptide, indicating
feasibility of the cytosensor for practical cancer cell quantification
in complex samples.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.